Rochester, MN8 Active Studies

Temporal Lobe Epilepsy Clinical Trials in Rochester, MN

Find 8 actively recruiting temporal lobe epilepsy clinical trials in Rochester, MN. Connect with local research sites and explore new treatment options.

8
Active Trials
7
Sponsors
1,103
Enrolling

Recruiting Temporal Lobe Epilepsy Studies in Rochester

About Temporal Lobe Epilepsy Clinical Trials in Rochester

Temporal lobe epilepsy is the most common form of focal epilepsy, with seizures originating in the temporal lobe of the brain. It can cause unusual sensations, memory problems, and altered consciousness. Treatment includes antiseizure medications and surgery for drug-resistant cases.

There are currently 8 temporal lobe epilepsy clinical trials recruiting participants in Rochester, MN. These studies are seeking a combined 1,103 participants. Research is being sponsored by Eli Lilly and Company, Academic and Community Cancer Research United, Emma Guttman and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Temporal Lobe Epilepsy Clinical Trials in Rochester — FAQ

Are there temporal lobe epilepsy clinical trials in Rochester?

Yes, there are 8 temporal lobe epilepsy clinical trials currently recruiting in Rochester, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rochester?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.

Are clinical trials in Rochester free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.

What temporal lobe epilepsy treatments are being tested?

The 8 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for temporal lobe epilepsy.

Data updated October 15, 2026 from ClinicalTrials.gov